|
|
Beta-carotene Vitamin A Vitamin D Vitamin E | |
|
Psyllium | |
|
Food | |
| Reduced drug absorption/bioavailability |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Beta-carotene
One well-controlled study showed that taking orlistat greatly reduces the absorption of
beta-carotene.1 Therefore, individuals taking orlistat for long periods of time
should probably supplement with beta-carotene.
Vitamin E
Taking orlistat dramatically reduces the absorption of vitamin E,2 which might
result in deficiency symptoms. Therefore, people taking orlistat for long periods of time
should supplement with vitamin E.
Vitamin A and Vitamin D
In one well-controlled study, taking orlistat for six months resulted in reduced blood levels
of vitamins A and D, though levels for most individuals remained within the normal range.
However, a few people developed levels low enough to require supplementation.3
Other studies have shown that taking orlistat had no affect on blood vitamin A
levels.4 5 Although additional research is needed, the current evidence
suggests that individuals taking orlistat for more than six months should supplement with
vitamins A and D.
Psyllium
In a group of obese women taking orlistat three times per day, ingestion of 6 grams of
psyllium with each dose of orlistat significantly reduced the gastrointestinal side effects of
the drug.6
Food
Orlistat blocks enzymes responsible for the breakdown and absorption of fat. Therefore,
orlistat should be taken during, or up to one hour after, each main meal that contains
fat.7
1. Zhi J, Melia AT, Koss-Twardy SG, et al. The effect of orlistat, an inhibitor of dietary fat absorption, on the pharmacokinetics of beta-carotene in healthy volunteers. J Clin Pharmacol 1996;36:152–9.
2. Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2693–6.
3. Van Gaal LF, Broom JI, Enzi G, Toplak H. Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose ranging study. Orlistat Dose-Ranging Study Group. Eur J Clin Pharmacol 1998;54:125–32.
4. Melia AT, Koss-Twardy SG, Zhi J. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J Clin Pharmacol 1996;36:647–53.
5. James WP, Aveell A, Broom J, Whitehead J. A one-year trial to assess the value of orlistat in the management of obesity. Int J Obes Relat Metab Disord 1997;21 Suppl 3:S24–30.
6. Cavaliere H, Floriano I, Medeiros-Neto G. Gastrointestinal side effects of orlistat may be prevented by concomitant prescription of natural fibers (psyllium mucilloid). Int J Obes Relat Metab Disord 2001;25:1095–9.
7. Sifton DW, ed. Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company, Inc., 2000, 2693–6.
| |||||||